Logo image of ARBK

ARGO BLOCKCHAIN PLC (ARBK) Stock Fundamental Analysis

NASDAQ:ARBK - Nasdaq - US0401261047 - ADR - Currency: USD

0.3748  0 (-0.35%)

After market: 0.38 +0.01 (+1.39%)

Fundamental Rating

2

ARBK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. ARBK has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ARBK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ARBK has reported negative net income.
In the past year ARBK has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ARBK reported negative net income in multiple years.
In the past 5 years ARBK reported 4 times negative operating cash flow.
ARBK Yearly Net Income VS EBIT VS OCF VS FCFARBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of ARBK (-302.51%) is worse than 95.77% of its industry peers.
Industry RankSector Rank
ROA -302.51%
ROE N/A
ROIC N/A
ROA(3y)-179.81%
ROA(5y)-104.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARBK Yearly ROA, ROE, ROICARBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

1.3 Margins

With a Gross Margin value of 5.20%, ARBK is not doing good in the industry: 86.97% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ARBK has declined.
The Profit Margin and Operating Margin are not available for ARBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-65%
GM growth 5Y-38.59%
ARBK Yearly Profit, Operating, Gross MarginsARBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1

2. Health

2.1 Basic Checks

ARBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARBK has been increased compared to 1 year ago.
ARBK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARBK is higher compared to a year ago.
ARBK Yearly Shares OutstandingARBK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ARBK Yearly Total Debt VS Total AssetsARBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -15.91, we must say that ARBK is in the distress zone and has some risk of bankruptcy.
ARBK's Altman-Z score of -15.91 is on the low side compared to the rest of the industry. ARBK is outperformed by 90.49% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -15.91
ROIC/WACCN/A
WACC10.34%
ARBK Yearly LT Debt VS Equity VS FCFARBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

ARBK has a Current Ratio of 1.24. This is a normal value and indicates that ARBK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.24, ARBK is doing worse than 60.92% of the companies in the same industry.
A Quick Ratio of 1.24 indicates that ARBK should not have too much problems paying its short term obligations.
The Quick ratio of ARBK (1.24) is worse than 60.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
ARBK Yearly Current Assets VS Current LiabilitesARBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

6

3. Growth

3.1 Past

ARBK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.99%.
Looking at the last year, ARBK shows a very strong growth in Revenue. The Revenue has grown by 26.30%.
ARBK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.40% yearly.
EPS 1Y (TTM)-38.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.71%
Revenue 1Y (TTM)26.3%
Revenue growth 3Y-21.91%
Revenue growth 5Y40.4%
Sales Q2Q%-36.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ARBK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 86.92% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year175.58%
Revenue Next 2Y86.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARBK Yearly Revenue VS EstimatesARBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ARBK Yearly EPS VS EstimatesARBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 0.5 -0.5 1 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARBK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARBK Price Earnings VS Forward Price EarningsARBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARBK Per share dataARBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ARBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARGO BLOCKCHAIN PLC

NASDAQ:ARBK (6/13/2025, 8:00:01 PM)

After market: 0.38 +0.01 (+1.39%)

0.3748

0 (-0.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-26 2025-08-26
Inst Owners8.12%
Inst Owner Change-37.98%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap23.85M
Analysts40
Price Target1.22 (225.51%)
Short Float %2.97%
Short Ratio4.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS1
BVpS-0.46
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -302.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.2%
FCFM N/A
ROA(3y)-179.81%
ROA(5y)-104.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-65%
GM growth 5Y-38.59%
F-Score3
Asset Turnover3.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z -15.91
F-Score3
WACC10.34%
ROIC/WACCN/A
Cap/Depr(3y)126.02%
Cap/Depr(5y)301.22%
Cap/Sales(3y)66.86%
Cap/Sales(5y)76.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.3%
Revenue growth 3Y-21.91%
Revenue growth 5Y40.4%
Sales Q2Q%-36.22%
Revenue Next Year175.58%
Revenue Next 2Y86.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-96.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.59%
OCF growth 3YN/A
OCF growth 5YN/A